Answer
Women of childbearing potential should use effective non-hormonal contraception during treatment with Itovebi (inavolisib) and for 1 week after the last dose.
Sources for this answer
- Itovebi 3 mg & 9mg film-coated tabletsRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked